Life Sciences Tools and Services
Company Overview of XenoGesis Ltd.
XenoGesis Ltd. operates as a laboratory-based contract research organization (CRO). The company specializes in preclinical drug metabolism and pharmacokinetics, quantitative bioanalysis, and expert interpretation. It also provides customized laboratory services; and consultancy services in the areas of data-driven iterative drug design, PK/PD study planning and interpretation, dosing regimen recommendations, toxicokinetic support, drug transport, and due diligence. XenoGesis Ltd. has a strategic alliance with Molecular Profiles Ltd. The company was founded in 2011 and is based in Nottingham, United Kingdom.
Nottingham, NG1 1GF
Founded in 2011
44 11 5837 0626
Key Executives for XenoGesis Ltd.
Similar Private Companies By Industry
|14M Genomics Ltd||Europe|
|Ablatus Therapeutics Limited||Europe|
|Accuro Biologics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact XenoGesis Ltd., please visit xenogesis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.